Curable composition for 3D printing method and 3D printing object formed therefrom and 3D printing method using the same

By using curable compositions containing ethylenically unsaturated groups and photoinitiators in 3D printing, the problem of insufficient thermal and mechanical properties of photopolymers in the prior art is solved, and high thermal deformation temperature and excellent mechanical properties are achieved. 3D printed objects, suitable for high stiffness applications in the automotive industry.

CN118973799AInactive Publication Date: 2024-11-15BASF SE
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202380031167.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-04-06
Filing Date
2023-03-31
Publication Date
2024-11-15
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing UV curable photopolymers are not thermally and mechanically sufficient to meet the automotive industry's demand for high thermal deformation temperatures and mechanical properties, especially when manufacturing plastic parts in vehicles.

Method used

A curable composition containing an ethylenically unsaturated group containing an isocyanurate structure and/or a tricyclodecane ring structure, combined with a photoinitiator, average glass transition calculated by the Fox equation The transition temperature reaches at least 373.15K, for forming 3D printed objects with high thermal deformation temperature and excellent mechanical properties.

Benefits of technology

It achieves a high thermal deformation temperature of at least 100°C under a load of 1.82 MPa, and has excellent mechanical properties, suitable for applications requiring high stiffness.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118973799A_ABST
    Figure CN118973799A_ABST
Patent Text Reader

Abstract

The present invention relates to a curable composition comprising: (A) at least one component containing ethylenically unsaturated groups wherein component (A) comprises a component (A1) comprising a structure (K) selected from isocyanurate structures and / or tricyclodecane ring structures; and (B) at least one photoinitiator wherein the average glass transition temperature (Tg, av) calculated from the curable composition using the following Fukes equation is at least 373.15 K, preferably at least 393.15 K, more preferably at least 423.15 K wherein Tg, i is the glass transition temperature in Kelvin of the homopolymer of component (i) making up component (A), and wi is the mass fraction of component (i) in component (A); relates to a method of forming a 3D printed object from the curable composition and a 3D printed object prepared therefrom. The 3D printed object obtained from the curable composition of the present invention has high HDT and excellent mechanical properties. # imgabs0 #
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a composition for three-dimensional (hereinafter referred to as "3D") printing. In particular, the present invention relates to a curable composition for 3D printing. The present invention further relates to a method for forming a 3D printed object by using the composition, and a 3D printed object formed therefrom. Background Art

[0002] 3D printing or additive manufacturing (AM) is a manufacturing method that aims to avoid traditional manufacturing techniques, which are either subtractive manufacturing techniques (i.e. machining and ablation) or form-based manufacturing techniques (i.e. molding and casting). In addition, 3D printing offers considerable benefits in terms of design freedom. UV-curable photopolymers are a class of 3D printable materials that have been widely used in various applications, including prototyping of plastic parts, metal investment casting, dental applications, etc. To date, UV-curable photopolymers available in the market are suitable for making prototypes and demonstrations, but are generally not sufficient for actual applications that require thermal and mechanical properties. In order to bridge the gap from prototyping to actual manufacturing, it is crucial to have advanced materials that have specific properties required by the target industrial applications.

[0003] The automotive industry is one of the most important consumer industries of polymers. The growing demand for fuel efficiency and lightweighting makes 3D printing a promising technology for manufacturing plastic components within vehicles, such as interior parts, connectors, and functional prototypes. These applications often require materials with sufficient heat deflection temperature (HDT) and mechanical properties, which is currently a challenging task.

[0004] Therefore, there is a strong need to provide curable compositions that will provide 3D printed objects with high heat deformation temperature (HDT) while having excellent mechanical properties. Summary of the invention

[0005] The object of the present invention is to provide a curable composition comprising (A) at least one component containing an ethylenically unsaturated group, wherein component (A) comprises component (A1) containing a structure (K) selected from an isocyanurate structure and / or a tricyclodecane ring structure. The cured product from the curable composition has a high HDT and excellent mechanical properties, in particular the cured product can reach a HDT of at least 100° C. under a load of 1.82 MPa as measured according to test standard ASTM D648-07, and will have excellent mechanical properties, such as those particularly suitable for applications where high stiffness is required.

[0006] Another object of the present invention is to provide a 3D printed object formed from the curable composition of the present invention.

[0007] A further object of the present invention is to provide a method for forming a 3D printed object by using the curable composition of the present invention.

[0008] It has been unexpectedly found that the above objects can be achieved by the following embodiments:

[0009] 1. A curable composition comprising:

[0010] (A) at least one component containing an ethylenically unsaturated group, wherein component (A) comprises component (A1) containing a structure (K) selected from an isocyanurate structure and / or a tricyclodecane ring structure; and

[0011] (B) at least one photoinitiator,

[0012] wherein the average glass transition temperature (Tg,av) calculated from the curable composition using the following Fox equation is at least 373.15 K, preferably at least 393.15 K, more preferably at least 423.15 K:

[0013]

[0014] wherein Tg,i is the glass transition temperature in Kelvin of the homopolymer of component (i) constituting component (A), and w i is the mass fraction of component (i) in component (A).

[0015] 2. The curable composition according to embodiment 1, wherein component (A1) contains at least 1 ethylenically unsaturated group, preferably 1 to 5 ethylenically unsaturated groups, more preferably 2 to 4 ethylenically unsaturated groups.

[0016] 3. The curable composition of embodiment 1 or 2, wherein the ethylenically unsaturated group is selected from the group consisting of allyl, vinyl, acrylate, methacrylate, acryloxy, methacryloyloxy, acrylamide, methacrylamide, ethynyl, and maleimide.

[0017] 4. The curable composition according to any one of embodiments 1 to 3, wherein component (A1) comprises or is tri(hydroxy-C 1-30 -alkyl) isocyanurate tri(meth)acrylate, preferably, component (A1) includes or comprises tri(2-hydroxyethyl)isocyanurate tri(meth)acrylate, tri(hydroxymethyl)isocyanurate tri(meth)acrylate, tri(3-hydroxy-n-propyl)isocyanurate tri(meth)acrylate, or any combination thereof.

[0018] 5. The curable composition according to any one of embodiments 1 to 4, wherein component (A1) comprises or is tricyclodecane-di-C 1-20 -Alkanol di(meth)acrylate, preferably tricyclodecane dimethanol di(meth)acrylate, tricyclodecane diethanol di(meth)acrylate, tricyclodecane dipropanol di(meth)acrylate, tricyclodecane dibutanol di(meth)acrylate, or tricyclodecane dipentanol di(meth)acrylate.

[0019] 6. The curable composition according to any one of embodiments 1 to 5, wherein the photoinitiator is a free radical photoinitiator and / or an ionic photoinitiator, preferably a free radical photoinitiator.

[0020] 7. The curable composition according to any one of embodiments 1 to 6, wherein the amount of component (A) is in the range of 80% to 99.9% by weight, preferably 90% to 99.9% by weight, more preferably 97% to 99.5% by weight, based on the total amount of the curable composition.

[0021] 8. The curable composition according to any one of embodiments 1 to 7, wherein the amount of component (A1) is in the range of 10 to 90% by weight, preferably 15 to 85% by weight, more preferably 20 to 80% by weight, based on the total amount of component (A).

[0022] 9. The curable composition according to any one of embodiments 1 to 8, wherein the amount of the photoinitiator is in the range of 0.1% to 8% by weight, preferably 0.1% to 5% by weight, more preferably 0.5% to 3% by weight, based on the total amount of the curable composition.

[0023] 10. The curable composition according to any one of embodiments 1 to 9, further comprising an auxiliary as component (C), such as a surfactant, a flame retardant, a pigment, a filler, a dye, a catalyst, a UV absorber and a stabilizer, and a reinforcing material, preferably in an amount of component (C) in the range of 0 to 18% by weight, preferably 0 to 15% by weight, more preferably 0 to 10% by weight, based on the total amount of the curable composition.

[0024] 11. The curable composition of any one of embodiments 1 to 10, wherein the cured product formed from the curable composition has a HDT value of at least 100°C, preferably at least 140°C, more preferably at least 190°C under a load of 1.82 MPa as measured according to test standard ASTM D648-07.

[0025] 12. The curable composition of any one of embodiments 1 to 11, wherein component (A) further comprises component (A2) that does not contain structure (K).

[0026] 13. A method of forming a 3D printed object, the method comprising using the curable composition according to any one of embodiments 1 to 12.

[0027] 14. The method of embodiment 13, comprising:

[0028] (i) applying the curable composition and curing the applied curable composition layer by layer by radiation to form an intermediate 3D printed object; and

[0029] (ii) curing the entire intermediate 3D printed object by radiation to form a cured 3D printed object.

[0030] 15. The method of embodiment 14, wherein in step (i) stereolithography, photopolymer jetting, digital light processing or LCD technology is used to form the intermediate 3D printed object.

[0031] 16. The method of embodiment 14 or 15, wherein the radiation is UV radiation.

[0032] 17. A 3D printed object formed from the curable composition according to any one of embodiments 1 to 12 or obtained by the method according to any one of embodiments 13 to 16.

[0033] 18. The 3D printed object of embodiment 17, wherein the 3D printed object comprises plastic parts within a vehicle, such as interior parts, connectors, and functional prototypes.

[0034] The 3D printed object obtained from the curable composition of the present invention has high HDT and excellent mechanical properties. In particular, it can reach an HDT of at least 100°C under a load of 1.82 MPa as measured according to test standard ASTM D648-07, such as at least 110°C, or at least 120°C, preferably at least 140°C, more preferably at least 190°C under a load of 1.82 MPa, and will have excellent mechanical properties, such as those particularly suitable for applications where high stiffness is required. DETAILED DESCRIPTION

[0035] Unless defined otherwise, all technical and scientific terms used herein have the meaning commonly understood by one of ordinary skill in the art to which the invention belongs. As used herein, the following terms have the meanings ascribed to them below unless otherwise indicated.

[0036] The singular articles "a," "an," and "the" refer to one or more of the substance represented by the term following the article.

[0037] As used in this disclosure, temperatures in degrees Celsius (° C.) and temperatures in Kelvin (K) have the following relationship: T(K)=T(° C.)+273.15.

[0038] In the context of this disclosure, any specific values ​​mentioned for features (including specific values ​​mentioned as endpoints in ranges) can be recombined to form new ranges.

[0039] Further embodiments of the invention can be seen from the claims, the description, the examples and the drawings. It is to be understood that the above-mentioned features of the subject matter of the invention and the features still to be elucidated below can be used not only in the specific combination indicated but also in other combinations without departing from the scope of the invention.

[0040] One aspect of the present invention relates to a curable composition comprising:

[0041] (A) at least one component containing an ethylenically unsaturated group, wherein component (A) comprises component (A1) containing a structure (K) selected from an isocyanurate structure and / or a tricyclodecane ring structure; and

[0042] (B) at least one photoinitiator,

[0043] wherein the average glass transition temperature (Tg,av) calculated from the curable composition using the following Fox equation is at least 373.15 K, preferably at least 393.15 K, more preferably at least 423.15 K:

[0044]

[0045] wherein Tg,i is the glass transition temperature in Kelvin of the homopolymer of component (i) constituting component (A), and w i is the mass fraction of component (i) in component (A).

[0046] Component (A)

[0047] The curable composition of the present invention comprises at least one component containing ethylenically unsaturated groups as component (A). In embodiments of the present invention, the ethylenically unsaturated groups contain carbon-carbon unsaturated bonds, such as those found in the following functional groups: allyl, vinyl, acrylate, methacrylate, acryloxy, methacryloyloxy, acrylamide, methacrylamide, ethynyl, maleimide, etc.

[0048] The amount of component (A) may be in the range of 80 to 99.9% by weight, for example 80% by weight, 82% by weight, 84% by weight, 86% by weight, 88% by weight, 90% by weight, 92% by weight, 94% by weight, 96% by weight, 98% by weight, 99% by weight, 99.9% by weight, such as 85 to 99.9% by weight, preferably 90 to 99.9% by weight, more preferably 95 to 99.9% by weight, or 97 to 99.5% by weight, based on the total weight of the curable composition of the present invention.

[0049] Component (A1)

[0050] Component (A) of the present invention comprises component (A1), which contains an ethylenically unsaturated group and a structure (K) selected from an isocyanurate structure and / or a tricyclodecane ring structure. Preferably, component (A1) contains at least one ethylenically unsaturated group, preferably 1 to 5 ethylenically unsaturated groups, more preferably 2 to 4 ethylenically unsaturated groups. In a preferred embodiment of the present invention, the ethylenically unsaturated group is selected from the group consisting of: allyl, vinyl, acrylate, methacrylate, acryloxy, methacryloyloxy, acrylamide, methacrylamide, ethynyl and maleimide.

[0051] In an embodiment of the present invention, component (A1) comprises or is a tri(meth)acrylate of tri(hydroxy-alkyl)isocyanurate, preferably tri(hydroxy-C 1-30 -alkyl) isocyanurate tri(meth)acrylate.

[0052] Preferably, the hydroxyl-C 1-30 -alkyl is selected from the group consisting of hydroxy-methyl, hydroxy-ethyl, hydroxy-propyl, hydroxy-butyl, hydroxy-pentyl, hydroxy-hexyl, hydroxy-octyl, hydroxy-nonyl, hydroxy-decyl, hydroxy-C 11 -alkyl, hydroxy-C 12 -alkyl, hydroxy-C 13 -alkyl, hydroxy-C 14 -alkyl, hydroxy-C 15 -alkyl, hydroxy-C 16 -alkyl, hydroxy-C 17 -alkyl, hydroxy-C 18 -alkyl, hydroxy-C 19 -alkyl, hydroxy-C 20 -alkyl, hydroxy-C 21 -alkyl, hydroxy-C 22 -alkyl, hydroxy-C 23 -alkyl, hydroxy-C24 -alkyl, hydroxy-C 25 -alkyl, hydroxy-C 26 -alkyl, hydroxy-C 27 -alkyl, hydroxy-C 28 -alkyl, hydroxy-C 29 -alkyl, hydroxy-C 30 -alkyl, more preferably selected from hydroxy-methyl, hydroxy-ethyl, hydroxy-propyl, hydroxy-butyl, hydroxy-pentyl, hydroxy-hexyl, hydroxy-octyl, hydroxy-nonyl and hydroxy-decyl.

[0053] Preferably, component (A1) includes or is tris-(2-hydroxyethyl)isocyanurate tri(meth)acrylate, tris(hydroxymethyl)isocyanurate tri(meth)acrylate, tris(3-hydroxy-n-propyl)isocyanurate tri(meth)acrylate, or any combination thereof.

[0054] In an embodiment of the present invention, component (A1) includes or is tricyclodecane-dialkanol di(meth)acrylate.

[0055] In a preferred embodiment of the present invention, component (A1) comprises or is tricyclodecane di-C 1-20 -alkanol di(meth)acrylates, such as tricyclodecane dimethanol di(meth)acrylate, tricyclodecane diethanol di(meth)acrylate, tricyclodecane dipropanol di(meth)acrylate, tricyclodecane dibutanol di(meth)acrylate, tricyclodecane dipentanol di(meth)acrylate, tricyclodecane di-C6-alkanol di(meth)acrylate, tricyclodecane di-C7-alkanol di(meth)acrylate, tricyclodecane di-C8-alkanol di(meth)acrylate, tricyclodecane di-C9-alkanol di(meth)acrylate, tricyclodecane di-C 10 -Alkyl di(meth)acrylate, tricyclodecane di-C 12 -Alkyl di(meth)acrylate, tricyclodecane di-C 14 -Alkyl di(meth)acrylate, tricyclodecane di-C 16 -Alkyl di(meth)acrylate, tricyclodecane di-C 18 -Alkyl di(meth)acrylate, tricyclodecane di-C 20 -alkanol di(meth)acrylate, and any combination thereof. Preferably, tricyclodecane-di-C 1-20The -alkanol di(meth)acrylates are tricyclodecane dimethanol di(meth)acrylate, tricyclodecane diethanol di(meth)acrylate, tricyclodecane dipropanol di(meth)acrylate, tricyclodecane dibutanol di(meth)acrylate, tricyclodecane dipentanol di(meth)acrylate, tricyclodecane di-C6-alkanol di(meth)acrylate, tricyclodecane di-C7-alkanol di(meth)acrylate, tricyclodecane di-C8-alkanol di(meth)acrylate, tricyclodecane di-C9-alkanol di(meth)acrylate, tricyclodecane di-C 10 -Alkyl di(meth)acrylate.

[0056] In an embodiment of the present invention, component (A1) may include or may be an isocyanurate having two or three allyl-alkyl groups as ethylenically unsaturated groups or a tricyclodecane having one or two allyl-alkyl groups as ethylenically unsaturated groups, such as a tricyclodecane having two or three allyl-C 1-20 Alkyl isocyanurate or having one or two allyl-C 1-20 For example, the allyl-alkyl group is selected from the group consisting of allyl-methyl, allyl-ethyl, allyl-propyl, allyl-butyl, allyl-pentyl, allyl-hexyl, allyl-octyl, allyl-nonyl, allyl-decyl, allyl-C 11 -alkyl, allyl-C 12 -alkyl, allyl-C 13 -alkyl, allyl-C 14 -alkyl, allyl-C 15 -alkyl, allyl-C 16 -alkyl, allyl-C 17 -alkyl, allyl-C 18 -alkyl, allyl-C 19 -alkyl, and allyl-C 20 -alkyl, more preferably, allyl-alkyl is selected from allyl-methyl, allyl-ethyl, allyl-propyl, allyl-butyl, allyl-pentyl, allyl-hexyl, allyl-octyl, allyl-nonyl and allyl-decyl. Preferably, the alkyl in allyl-alkyl is inserted with one or more heteroatoms, preferably one or two or three heteroatoms, such as O, N or S, preferably O or N, at the end of the alkyl or in the middle of the alkyl; or the alkyl in allyl-alkyl is inserted with groups such as carbonyl, amino and acyloxy at the end of the alkyl or in the middle of the alkyl.

[0057] In preferred embodiments of the present invention, Sartomer SR368 available from Sartomer Co., Exton, PA. and Sartomer SR833S available from Sartomer Co., Exton, PA. may be used as component (A1) of the present invention.

[0058] The amount of component (A1) may be in the range of 10 to 90% by weight, for example 15% by weight, 20% by weight, 25% by weight, 30% by weight, 35% by weight, 40% by weight, 45% by weight, 50% by weight, 55% by weight, 60% by weight, 70% by weight, 80% by weight, 85% by weight, 86% by weight, 87% by weight, 88% by weight, 89% by weight, 90% by weight, 91% by weight, 92% by weight, 93% by weight, 94% by weight, 96% by weight, 97% by weight, 98% by weight, 99% by weight, 100% by weight, 101% by weight, 102% by weight, 103% by weight, 104% by weight, 105% by weight, 106% by weight, 107% by weight, 108% by weight, 109% by weight, 110% by weight, 111% by weight, 112% by weight, 113% by weight, 114% by weight, 115% by weight, 116% by weight, 117% by weight, 118% by weight, % by weight, or 15% to 85% by weight, or 20% to 85% by weight, or 25% to 85% by weight, or 30% to 85% by weight, or 10% to 80% by weight, or 15% to 80% by weight, or 20% to 80% by weight, or 25% to 80% by weight, or 30% to 80% by weight.

[0059] Component (A2)

[0060] Preferably, component (A) of the present invention further comprises component (A2). Component (A2) of the present invention contains ethylenically unsaturated groups, but does not contain structure (K). In a preferred embodiment of the present invention, the ethylenically unsaturated groups are selected from the group consisting of: allyl, vinyl, acrylate, methacrylate, acryloxy, methacryloyloxy, acrylamide, methacrylamide, ethynyl, maleimide, etc.

[0061] In an embodiment of the present invention, component (A2) of the present invention contains, in addition to the ethylenically unsaturated groups, urethane groups, ether groups, ester groups, carbonate groups and any combination thereof.

[0062] In an embodiment of the present invention, component (A2) of the present invention comprises monomers and / or oligomers containing ethylenically unsaturated groups.

[0063] Component (A2) of the present invention can comprise oligomer, and these oligomers contain the core structure that is connected to ethylenically unsaturated groups via linking group alternatively, and wherein core structure neither structure (K) nor contains structure (K).Linking group can be ether, ester, amide, carbamate or carbonate group that do not contain structure (K).In some cases, linking group is the part of ethylenically unsaturated groups (for example acryloxy or acrylamide).Core group can be alkyl (straight chain and branched alkyl), aryl (for example, phenyl), polyether, polyester, siloxane, carbamate or other core structure and oligomer thereof.

[0064] In some embodiments, as component (A2) of the present invention, the oligomer having an ethylenically unsaturated group can be selected from the following categories: urethane (i.e., urethane-based oligomer having an ethylenically unsaturated group), polyether (i.e., polyether-based oligomer having an ethylenically unsaturated group), polyester (i.e., polyester-based oligomer having an ethylenically unsaturated group), polycarbonate (i.e., polycarbonate-based oligomer having an ethylenically unsaturated group), polyestercarbonate (i.e., polyestercarbonate-based oligomer having an ethylenically unsaturated group), epoxy (i.e., epoxy-based oligomer having an ethylenically unsaturated group), silicone (i.e., silicone-based oligomer having an ethylenically unsaturated group), or any combination thereof. Preferably, the oligomer having an ethylenically unsaturated group may be selected from the following categories: urethane-based oligomers, epoxy-based oligomers, polyester-based oligomers, polyether-based oligomers, polyether urethane-based oligomers, polyester urethane-based oligomers or silicone-based oligomers, and any combination thereof.

[0065] In a preferred embodiment of the present invention, as component (A2) of the present invention, the oligomer with ethylenically unsaturated groups includes an oligomer based on carbamate, which has a carbamate repeating unit and one, two or more ethylenically unsaturated groups, such as those containing carbon-carbon unsaturated double bonds, such as (methyl) acrylate groups, (methyl) acrylamide groups, allyl groups and vinyl groups. Preferably, the oligomer contains at least one carbamate bond (for example, one, two or more carbamate bonds) in the skeleton of the oligomer molecule and at least one acrylate and / or methacrylate functional group (for example, one, two or more acrylate and / or methacrylate functional groups) side-connected to the oligomer molecule. In certain embodiments, aliphatic, alicyclic or mixed aliphatic and alicyclic carbamate repeating units are suitable. Carbamate is typically prepared by the condensation of diisocyanates and diols. It is useful that each repeating unit has an aliphatic carbamate with at least two carbamate moieties. Furthermore, the diisocyanates and diols used to prepare the urethanes contain divalent aliphatic groups which may be the same or different.

[0066] In one embodiment, as component (A2) of the present invention, the oligomer having an ethylenically unsaturated group includes a polyester urethane-based oligomer or a polyether urethane-based oligomer having at least one ethylenically unsaturated group. The ethylenically unsaturated group may be those containing a carbon-carbon unsaturated double bond, such as an acrylate group, a methacrylate group, a vinyl group, an allyl group, an acrylamide group, a methacrylamide group, etc., preferably an acrylate group and a methacrylate group.

[0067] Suitable oligomers based on carbamates are known in the art and can be easily synthesized by a variety of different procedures. For example, a polyfunctional alcohol can react with a polyisocyanate (preferably, a stoichiometric excess of polyisocyanate) to form an NCO-terminated pre-oligomer, which is thereafter reacted with a hydroxy-functional ethylenically unsaturated monomer (such as a hydroxy-functional (meth) acrylate). The polyfunctional alcohol can be any compound containing two or more OH groups per molecule, and can be a monomeric polyol (e.g., a diol), a polyester polyol, a polyether polyol, etc. In one embodiment of the invention, the oligomer based on carbamates is an oligomer based on aliphatic carbamates with a (meth) acrylate functional group.

[0068] Suitable oligomers based on polyether or polyester urethanes include the reaction products of aliphatic or aromatic polyether or polyester polyols and aliphatic or aromatic polyisocyanates functionalized with monomers containing ethylenically unsaturated groups such as (meth)acrylate groups. In a preferred embodiment, the polyether and polyester are aliphatic polyethers and polyesters, respectively. In a preferred embodiment, the oligomers based on polyether and polyester urethanes are oligomers based on aliphatic polyether and polyester urethanes and contain (meth)acrylate groups.

[0069] In one embodiment, as component (A2) of the present invention, the viscosity of the oligomer having ethylenically unsaturated groups at 60° C. as measured according to DIN EN ISO 3219 may be in the range of 2000 to 100000 cP, for example, 3000 cP, 4000 cP, 5000 cP, 6000 cP, 7000 cP, 8000 cP, 10000 cP, 20000 cP, 30000 cP, 40000 cP, 50000 cP, 60000 cP, 70000 cP, 80000 cP, 90000 cP, 95000 cP, preferably 4000 to 60000 cP, for example, 4000 to 15000 cP, or 20000 cP to 60000 cP.

[0070] The monomer can reduce the viscosity of the curable composition of the present invention. As component (A2) of the present invention, the monomer can be monofunctional or multifunctional (such as difunctional, trifunctional). In one embodiment, the monomer can be selected from the group consisting of: (meth) acrylate monomers, (meth) acrylamide monomers, vinyl aromatic compounds with up to 20 carbon atoms, vinyl esters of carboxylic acids with up to 20 carbon atoms, α, β-unsaturated carboxylic acids with 3 to 8 carbon atoms and their anhydrides.

[0071] In the context of the present disclosure, the term "(meth)acrylate monomer" means a monomer comprising a (meth)acrylate moiety. The structure of the (meth)acrylate moiety is as follows:

[0072]

[0073] wherein R is H or methyl.

[0074] As component (A2) of the present invention, the (meth)acrylate monomer may be a monofunctional or multifunctional (such as a difunctional, trifunctional) (meth)acrylate monomer. Exemplary (meth)acrylate monomers may include (meth)acrylic acid C1 to C 20 Alkyl esters, (meth)acrylic acid C1 to C 10 Hydroxyalkyl esters, caprolactone (meth)acrylate, phenyl (meth)acrylate, benzyl (meth)acrylate and phenethyl (meth)acrylate.

[0075] (Meth) acrylic acid C1 to C 20 Specific examples of the alkyl ester may include methyl (meth)acrylate, ethyl (meth)acrylate, isopropyl (meth)acrylate, n-propyl (meth)acrylate, n-butyl (meth)acrylate, isobutyl (meth)acrylate, tert-butyl (meth)acrylate, sec-butyl (meth)acrylate, amyl (meth)acrylate, n-hexyl (meth)acrylate, octyl (meth)acrylate, isooctyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, decyl (meth)acrylate, isodecyl (meth)acrylate, n-lauryl (meth)acrylate, n-tridecyl (meth)acrylate, n-cetyl (meth)acrylate, n-stearyl (meth)acrylate, isomyristyl (meth)acrylate, stearyl (meth)acrylate, and isostearyl (meth)acrylate (ISTA). Preferably, C6 to C8 (meth)acrylate is used. 18 Alkyl esters, especially (meth) acrylic acid C6 to C 16 Alkyl ester or (meth) acrylic acid C8 to C 12 Alkyl esters.

[0076] (Meth) acrylic acid C1 to C 10Specific examples of hydroxyalkyl esters, such as C2 to C8 hydroxyalkyl (meth)acrylates, may include 2-hydroxyethyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, 3-hydroxypropyl (meth)acrylate, 3-hydroxybutyl (meth)acrylate, 4-hydroxybutyl (meth)acrylate, 6-hydroxyhexyl (meth)acrylate, or 3-hydroxy-2-ethylhexyl (meth)acrylate, etc.

[0077] In the context of the present disclosure, the term "(meth)acrylamide monomer" means a monomer comprising a (meth)acrylamide moiety. The structure of the (meth)acrylamide moiety is as follows: CH2=CR 1 -CO-N, where R 1 Specific examples of the (meth)acrylamide monomer may include N-(hydroxymethyl)acrylamide, N-hydroxyethylacrylamide, N-isopropylacrylamide, N-isopropylmethacrylamide, N-tert-butylacrylamide, N,N'-methylenebisacrylamide, N-(isobutoxymethyl)acrylamide, N-(butoxymethyl)acrylamide, N-[3-(dimethylamino)propyl]methacrylamide, N,N-dimethylacrylamide, N,N-diethylacrylamide, N-(hydroxymethyl)methacrylamide, N-hydroxyethylmethacrylamide, N-isopropylmethacrylamide, N-isopropylmethacrylamide, N-tert-butylmethacrylamide, N,N'-methylenebismethacrylamide, N-(isobutoxymethyl)methacrylamide, N-(butoxymethyl)methacrylamide, N-[3-(dimethylamino)propyl]methacrylamide, N,N-dimethylmethacrylamide, and N,N-diethylmethacrylamide. The (meth)acrylamide monomers may be used alone or in combination.

[0078] Examples of vinyl aromatic compounds having up to 20 carbon atoms may include, for example, styrene and C1-C4-alkyl-substituted styrenes such as vinyltoluene, p-tert-butylstyrene and α-methylstyrene.

[0079] Examples of the vinyl ester of carboxylic acid having up to 20 carbon atoms (eg, 2 to 20 or 8 to 18 carbon atoms) may include vinyl laurate, vinyl stearate, vinyl propionate, and vinyl acetate.

[0080] Examples of the α,β-unsaturated carboxylic acid having 3 to 8 carbon atoms may be acrylic acid or methacrylic acid.

[0081] Preferred monomers are (meth)acrylate monomers, (meth)acrylamide monomers, and vinyl aromatic compounds having up to 20 carbon atoms.

[0082] In a preferred embodiment, component (A2) of the present invention comprises both oligomers and monomers containing ethylenically unsaturated groups. The weight ratio of oligomer to monomer can be in the range of 10:1 to 1:10, preferably 8:1 to 1:8, or 5:1 to 1:5, or 3:1 to 1:5, or 1:1 to 1:4.

[0083] In a preferred embodiment of the present invention, component (A2) of the present invention is selected from the group consisting of: Rahn Genomer 4247 available from Rahn, Dymax BR952 available from Dymax, acryloyl morpholine (ACMO) available from Rahn; and isobornyl methacrylate (IBOMA) available from Miwon.

[0084] Photoinitiator (B)

[0085] The curable composition of the present invention comprises at least one photoinitiator as component (B). For example, the photoinitiator component (B) may include at least one free radical photoinitiator and / or at least one ionic photoinitiator, and preferably at least one (e.g., one or two) free radical photoinitiator. All photoinitiators known in the art for use in compositions for 3D printing can be used, for example, photoinitiators known in the art suitable for stereolithography (SLA), digital light processing (DLP) or photopolymer jetting (PPJ) processes can be used.

[0086] As examples of photoinitiators for the invention, use may be made of those mentioned in: "Advances in Polymer Science", Vol. 14, Springer Berlin 1974 or KK Dietliker, Chemistry and Technology of UV and EB Formulation for Coatings, Inks and Paints, Vol. 3; Photo-initiators for Free Radical and Cationic Polymerization, PKT Oldring (ed.), SITA Technology Ltd, London.

[0087] Suitable examples include phosphine oxides, benzophenones, α-hydroxyalkyl aryl ketones, thioxanthones, anthraquinones, acetophenones, benzoins and benzoin ethers, ketals, imidazoles or phenylglyoxylic acids, and mixtures thereof.

[0088] The phosphine oxides are, for example, monoacyl or bisacyl phosphine oxides, such as 819 (bis(2,4,6-trimethylbenzoyl)phenylphosphine oxide), as described, for example, in EP-A 7 508, EP-A 57 474, DE-A 196 18 720, EP-A 495 751 or EP-A 615 980, as 2,4,6-trimethylbenzoyldiphenylphosphine oxide ( TPO), ethyl 2,4,6-trimethylbenzoylphenylphosphinate or bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphine oxide;

[0089] Benzophenones are, for example, benzophenone, 4-aminobenzophenone, 4,4′-bis(dimethylamino)benzophenone, 4-phenylbenzophenone, 4-chlorobenzophenone, Michler's ketone, o-methoxybenzophenone, 2,4,6-trimethylbenzophenone, 4-methylbenzophenone, 2,4-dimethylbenzophenone, 4-isopropylbenzophenone, 2-chlorobenzophenone, 2,2′-dichlorobenzophenone, 4-methoxybenzophenone, 4-propoxybenzophenone or 4-butoxybenzophenone;

[0090] α-Hydroxyalkyl aryl ketones are, for example, 1-benzoylcyclohexan-1-ol (1-hydroxycyclohexyl phenyl ketone), 2-hydroxy-2,2-dimethylacetophenone (2-hydroxy-2-methyl-1-phenylpropan-1-one), 1-hydroxyacetophenone, 1-[4-(2-hydroxyethoxy)phenyl]-2-hydroxy-2-methyl-1-propan-1-one or polymers containing 2-hydroxy-2-methyl-1-(4-isopropen-2-ylphenyl)propan-1-one in copolymerized form ( KIP 150);

[0091] Xanthones and thioxanthones are, for example, 10-thioxanthone, thioxanth-9-one, xanth-9-one, 2,4-dimethylthioxanthone, 2,4-diethylthioxanthone, 2,4-diisopropylthioxanthone, 2,4-dichlorothioxanthone or chloroxanthone;

[0092] Anthraquinones are, for example, β-methylanthraquinone, tert-butylanthraquinone, anthraquinonecarboxylate, benz[de]anthraquinone-7-one, benz[a]anthraquinone-7,12-dione, 2-methylanthraquinone, 2-ethylanthraquinone, 2-tert-butylanthraquinone, 1-chloroanthraquinone or 2-amylanthraquinone;

[0093] Acetophenones are, for example, acetophenone, acetylnaphthoquinone, valerophenone, hexanophenone, α-phenylbutyrophenone, p-morpholinopropiophenone, dibenzosuberone, 4-morpholinobenzophenone, p-diacetylbenzene, 4′-methoxyacetophenone, α-tetralone, 9-acetylphenanthrene, 2-acetylphenanthrene, 3-acetylphenanthrene, 3-acetylindole, 9-fluorenone, 1-indanone, 1,3,4-triacetylbenzene, 1-acetonaphthone, 2-acetonaphthone, 2,2-dimethoxy-2-phenylacetophenone, 2,2-diethoxy-2-phenylacetophenone, 1,1-dichloroacetophenone, 1-hydroxyacetophenone, 2,2-diethoxyacetophenone, 2-methyl-1-[4-(methylthio)phenyl]-2-morpholinopropan-1-one, 2,2-dimethoxy-1,2-diphenylethan-2-one or 2-benzyl-2-dimethylamino-1-(4-morpholinophenyl)butan-1-one;

[0094] Benzoins and benzoin ethers are, for example, 4-morpholinodeoxybenzoin, benzoin, benzoin isobutyl ether, benzoin tetrahydropyranyl ether, benzoin methyl ether, benzoin ethyl ether, benzoin butyl ether, benzoin isopropyl ether or 7H-benzoin methyl ether; and

[0095] Ketals are, for example, acetophenone dimethyl ketal, 2,2-diethoxyacetophenone, or benzil ketals such as benzil dimethyl ketal.

[0096] Phenylglyoxylic acids are described, for example, in DE-A 198 26 712, DE-A 199 13 353 or WO 98 / 33761.

[0097] Photoinitiators which may also be used are, for example, benzaldehyde, methyl ethyl ketone, 1-naphthaldehyde, triphenylphosphine, tri-o-tolylphosphine or 2,3-butanedione.

[0098] Suitable mixtures of photoinitiators may also be used. Typical mixtures include, for example:

[0099] 2-Hydroxy-2-methyl-1-phenylpropan-2-one and 1-hydroxycyclohexylphenylketone;

[0100] Bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphine oxide and 2-hydroxy-2-methyl-1-phenylpropan-1-one;

[0101] Benzophenone and 1-hydroxycyclohexylphenyl ketone;

[0102] Bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphine oxide and 1-hydroxycyclohexylphenylketone;

[0103] 2,4,6-Trimethylbenzoyldiphenylphosphine oxide and 2-hydroxy-2-methyl-1-phenylpropan-1-one;

[0104] 2,4,6-Trimethylbenzophenone and 4-methylbenzophenone; or

[0105] 2,4,6-Trimethylbenzophenone and 4-methylbenzophenone and

[0106] 2,4,6-Trimethylbenzoyldiphenylphosphine oxide.

[0107] The amount of the photoinitiator (B) may be in the range of 0.1% to 8% by weight, for example 0.2% by weight, 0.3% by weight, 0.4% by weight, 0.5% by weight, 0.6% by weight, 0.7% by weight, 0.8% by weight, 0.9% by weight, 1% by weight, 2% by weight, 3% by weight, 4% by weight, 5% by weight, 6% by weight, 7% by weight, or 8% by weight, preferably 0.1% to 7%, or 0.1% to 6%, or 0.1% to 5%, more preferably 0.4% to 6%, or 0.4% to 5%, or 0.5% to 5%, or 0.5% to 3% by weight, based on the total weight of the curable composition of the present invention.

[0108] Curable composition

[0109] The curable composition of the present invention comprises:

[0110] (A) at least one component containing an ethylenically unsaturated group, wherein component (A) comprises component (A1) containing a structure (K) selected from an isocyanurate structure and / or a tricyclodecane ring structure; and

[0111] (B) at least one photoinitiator,

[0112] wherein the average glass transition temperature (Tg,av) calculated from the curable composition using the following Fox equation is at least 373.15 K, preferably at least 393.15 K, more preferably at least 423.15 K:

[0113]

[0114] wherein Tg,i is the glass transition temperature in Kelvin of the homopolymer of component (i) constituting component (A), and w i is the mass fraction of component (i) in component (A).

[0115] Preferably, component (A) further comprises component (A2) which does not contain structure (K).

[0116] Surprisingly, it has been found that using the curable composition of the present invention, the cured product obtained therefrom has a high HDT and excellent mechanical properties. In particular, the cured product obtained from the curable composition of the present invention can reach an HDT of at least 100°C, preferably at least 140°C, more preferably at least 190°C under a load of 1.82 MPa as measured according to test standard ASTM D648-07, and will have excellent mechanical properties, such as those particularly suitable for applications where high stiffness is required.

[0117] In one embodiment, the curable composition of the present invention comprises:

[0118] (A) 80 to 99.9% by weight of at least one component containing an ethylenically unsaturated group, wherein component (A) comprises component (A1) containing a structure (K) selected from an isocyanurate structure and / or a tricyclodecane ring structure; and

[0119] (B) 0.1 to 8% by weight of at least one photoinitiator,

[0120] wherein the amount of component (A1) is in the range of 10 to 90% by weight, preferably 15 to 85% by weight, more preferably 20 to 80% by weight, based on the total amount of component (A),

[0121] wherein the average glass transition temperature (Tg,av) calculated from the curable composition using the following Fox equation is at least 373.15 K, preferably at least 393.15 K, more preferably at least 423.15 K:

[0122]

[0123] wherein Tg,i is the glass transition temperature in Kelvin of the homopolymer of component (i) constituting component (A), and w i is the mass fraction of component (i) in component (A).

[0124] In one embodiment, the curable composition of the present invention comprises:

[0125] (A) 90 to 99.9% by weight of at least one component containing an ethylenically unsaturated group, wherein component (A) comprises component (A1) containing a structure (K) selected from an isocyanurate structure and / or a tricyclodecane ring structure; and

[0126] (B) 0.1 to 5% by weight of at least one photoinitiator,

[0127] wherein the amount of component (A1) is in the range of 10 to 90% by weight, preferably 15 to 85% by weight, more preferably 20 to 80% by weight, based on the total amount of component (A),

[0128] wherein the average glass transition temperature (Tg,av) calculated from the curable composition using the following Fox equation is at least 373.15 K, preferably at least 393.15 K, more preferably at least 423.15 K:

[0129]

[0130] wherein Tg,i is the glass transition temperature in Kelvin of the homopolymer of component (i) constituting component (A), and w i is the mass fraction of component (i) in component (A).

[0131] In one embodiment, the curable composition of the present invention comprises:

[0132] (A) 97% to 99.5% by weight of at least one component containing an ethylenically unsaturated group, wherein component (A) comprises component (A1) containing a structure (K) selected from an isocyanurate structure and / or a tricyclodecane ring structure; and

[0133] (B) 0.1 to 3% by weight of at least one photoinitiator,

[0134] wherein the amount of component (A1) is in the range of 10 to 90% by weight, preferably 15 to 85% by weight, more preferably 20 to 80% by weight, based on the total amount of component (A),

[0135] wherein the average glass transition temperature (Tg,av) calculated from the curable composition using the following Fox equation is at least 373.15 K, preferably at least 393.15 K, more preferably at least 423.15 K:

[0136]

[0137] wherein Tg,i is the glass transition temperature in Kelvin of the homopolymer of component (i) constituting component (A), and w i is the mass fraction of component (i) in component (A).

[0138] In one embodiment, the curable composition of the present invention comprises:

[0139] (A) 80 to 99.9% by weight of at least one component containing an ethylenically unsaturated group, wherein component (A) comprises component (A1) containing a structure (K) selected from an isocyanurate structure and / or a tricyclodecane ring structure; and

[0140] (B) 0.1 to 8% by weight of at least one photoinitiator,

[0141] wherein the amount of component (A1) is in the range of 10 to 90% by weight, preferably 15 to 85% by weight, more preferably 20 to 80% by weight, based on the total amount of component (A),

[0142] wherein the average glass transition temperature (Tg,av) calculated from the curable composition using the following Fox equation is at least 373.15 K, preferably at least 393.15 K, more preferably at least 423.15 K:

[0143]

[0144] wherein Tg,i is the glass transition temperature in Kelvin of the homopolymer of component (i) constituting component (A), and w i is the mass fraction of component (i) in component (A),

[0145] Wherein component (A1) comprises or is tri(hydroxy-C 1-30 -alkyl) isocyanurate tri(meth)acrylate,

[0146] Tri(hydroxy-alkyl)isocyanurate tri(meth)acrylate hydroxy-C 1-30 -alkyl is selected from the group consisting of hydroxy-methyl, hydroxy-ethyl, hydroxy-propyl, hydroxy-butyl, hydroxy-pentyl, hydroxy-hexyl, hydroxy-octyl, hydroxy-nonyl, hydroxy-decyl, hydroxy-C 11 -alkyl, hydroxy-C 12 -alkyl, hydroxy-C 13 -alkyl, hydroxy-C 14 -alkyl, hydroxy-C 15 -alkyl, hydroxy-C 16 -alkyl, hydroxy-C 17 -alkyl, hydroxy-C 18 -alkyl, hydroxy-C 19 -alkyl, hydroxy-C 20 -alkyl, hydroxy-C 21 -alkyl, hydroxy-C 22 -alkyl, hydroxy-C 23 -alkyl, hydroxy-C 24 -alkyl, hydroxy-C 25 -alkyl, hydroxy-C 26 -alkyl, hydroxy-C 27 -alkyl, hydroxy-C 28 -alkyl, hydroxy-C 29 -alkyl, hydroxy-C 30-alkyl, preferably selected from hydroxy-methyl, hydroxy-ethyl, hydroxy-propyl, hydroxy-butyl, hydroxy-pentyl, hydroxy-hexyl, hydroxy-octyl, hydroxy-nonyl and hydroxy-decyl.

[0147] In one embodiment, the curable composition of the present invention comprises:

[0148] (A) 90 to 99.9% by weight of at least one component containing an ethylenically unsaturated group, wherein component (A) comprises component (A1) containing a structure (K) selected from an isocyanurate structure and / or a tricyclodecane ring structure; and

[0149] (B) 0.1 to 5% by weight of at least one photoinitiator,

[0150] wherein the amount of component (A1) is in the range of 10 to 90% by weight, preferably 15 to 85% by weight, more preferably 20 to 80% by weight, based on the total amount of component (A),

[0151] wherein the average glass transition temperature (Tg,av) calculated from the curable composition using the following Fox equation is at least 373.15 K, preferably at least 393.15 K, more preferably at least 423.15 K:

[0152]

[0153] wherein Tg,i is the glass transition temperature in Kelvin of the homopolymer of component (i) constituting component (A), and w i is the mass fraction of component (i) in component (A),

[0154] Wherein component (A1) comprises or is tri(hydroxy-C 1-30 -alkyl) isocyanurate tri(meth)acrylate,

[0155] Tri(hydroxy-alkyl)isocyanurate tri(meth)acrylate hydroxy-C 1-30 -alkyl is selected from the group consisting of hydroxy-methyl, hydroxy-ethyl, hydroxy-propyl, hydroxy-butyl, hydroxy-pentyl, hydroxy-hexyl, hydroxy-octyl, hydroxy-nonyl, hydroxy-decyl, hydroxy-C 11 -alkyl, hydroxy-C 12 -alkyl, hydroxy-C 13 -alkyl, hydroxy-C 14 -alkyl, hydroxy-C 15 -alkyl, hydroxy-C 16 -alkyl, hydroxy-C 17 -alkyl, hydroxy-C 18 -alkyl, hydroxy-C 19 -alkyl, hydroxy-C20 -alkyl, hydroxy-C 21 -alkyl, hydroxy-C 22 -alkyl, hydroxy-C 23 -alkyl, hydroxy-C 24 -alkyl, hydroxy-C 25 -alkyl, hydroxy-C 26 -alkyl, hydroxy-C 27 -alkyl, hydroxy-C 28 -alkyl, hydroxy-C 29 -alkyl, hydroxy-C 30 -alkyl, preferably selected from hydroxy-methyl, hydroxy-ethyl, hydroxy-propyl, hydroxy-butyl, hydroxy-pentyl, hydroxy-hexyl, hydroxy-octyl, hydroxy-nonyl and hydroxy-decyl.

[0156] In one embodiment, the curable composition of the present invention comprises:

[0157] (A) 97% to 99.5% by weight of at least one component containing an ethylenically unsaturated group, wherein component (A) comprises component (A1) containing a structure (K) selected from an isocyanurate structure and / or a tricyclodecane ring structure; and

[0158] (B) 0.1 to 3% by weight of at least one photoinitiator,

[0159] wherein the amount of component (A1) is in the range of 10 to 90% by weight, preferably 15 to 85% by weight, more preferably 20 to 80% by weight, based on the total amount of component (A),

[0160] wherein the average glass transition temperature (Tg,av) calculated from the curable composition using the following Fox equation is at least 373.15 K, preferably at least 393.15 K, more preferably at least 423.15 K:

[0161]

[0162] wherein Tg,i is the glass transition temperature in Kelvin of the homopolymer of component (i) constituting component (A), and w i is the mass fraction of component (i) in component (A),

[0163] Wherein component (A1) comprises or is tri(hydroxy-C 1-30 -alkyl) isocyanurate tri(meth)acrylate,

[0164] Tri(hydroxy-alkyl)isocyanurate tri(meth)acrylate hydroxy-C 1-30-alkyl is selected from the group consisting of hydroxy-methyl, hydroxy-ethyl, hydroxy-propyl, hydroxy-butyl, hydroxy-pentyl, hydroxy-hexyl, hydroxy-octyl, hydroxy-nonyl, hydroxy-decyl, hydroxy-C 11 -alkyl, hydroxy-C 12 -alkyl, hydroxy-C 13 -alkyl, hydroxy-C 14 -alkyl, hydroxy-C 15 -alkyl, hydroxy-C 16 -alkyl, hydroxy-C 17 -alkyl, hydroxy-C 18 -alkyl, hydroxy-C 19 -alkyl, hydroxy-C 20 -alkyl, hydroxy-C 21 -alkyl, hydroxy-C 22 -alkyl, hydroxy-C 23 -alkyl, hydroxy-C 24 -alkyl, hydroxy-C 25 -alkyl, hydroxy-C 26 -alkyl, hydroxy-C 27 -alkyl, hydroxy-C 28 -alkyl, hydroxy-C 29 -alkyl, hydroxy-C 30 -alkyl, preferably selected from hydroxy-methyl, hydroxy-ethyl, hydroxy-propyl, hydroxy-butyl, hydroxy-pentyl, hydroxy-hexyl, hydroxy-octyl, hydroxy-nonyl and hydroxy-decyl.

[0165] In one embodiment, the curable composition of the present invention comprises:

[0166] (A) 80 to 99.9% by weight of at least one component containing an ethylenically unsaturated group, wherein component (A) comprises component (A1) containing a structure (K) selected from an isocyanurate structure and / or a tricyclodecane ring structure; and

[0167] (B) 0.1 to 8% by weight of at least one photoinitiator,

[0168] wherein the amount of component (A1) is in the range of 10 to 90% by weight, preferably 15 to 85% by weight, more preferably 20 to 80% by weight, based on the total amount of component (A),

[0169] wherein the average glass transition temperature (Tg,av) calculated from the curable composition using the following Fox equation is at least 373.15 K, preferably at least 393.15 K, more preferably at least 423.15 K:

[0170]

[0171] wherein Tg,i is the glass transition temperature in Kelvin of the homopolymer of component (i) constituting component (A), and w i is the mass fraction of component (i) in component (A),

[0172] Wherein component (A1) comprises or is tricyclodecane di-C 1-20 -alkanol di(meth)acrylates, such as tricyclodecane dimethanol di(meth)acrylate, tricyclodecane diethanol di(meth)acrylate, tricyclodecane dipropanol di(meth)acrylate, tricyclodecane dibutanol di(meth)acrylate, tricyclodecane dipentanol di(meth)acrylate, tricyclodecane di-C6-alkanol di(meth)acrylate, tricyclodecane di-C7-alkanol di(meth)acrylate, tricyclodecane di-C8-alkanol di(meth)acrylate, tricyclodecane di-C9-alkanol di(meth)acrylate, tricyclodecane di-C 10 -Alkyl di(meth)acrylate, tricyclodecane di-C 12 -Alkyl di(meth)acrylate, tricyclodecane di-C 14 -Alkyl di(meth)acrylate, tricyclodecane di-C 16 -Alkyl di(meth)acrylate, tricyclodecane di-C 18 -Alkyl di(meth)acrylate, tricyclodecane di-C 20 -Alkyl alcohol di(meth)acrylate, and any combination thereof.

[0173] In one embodiment, the curable composition of the present invention comprises:

[0174] (A) 90 to 99.9% by weight of at least one component containing an ethylenically unsaturated group, wherein component (A) comprises component (A1) containing a structure (K) selected from an isocyanurate structure and / or a tricyclodecane ring structure; and

[0175] (B) 0.1 to 5% by weight of at least one photoinitiator,

[0176] wherein the amount of component (A1) is in the range of 10 to 90% by weight, preferably 15 to 85% by weight, more preferably 20 to 80% by weight, based on the total amount of component (A),

[0177] wherein the average glass transition temperature (Tg,av) calculated from the curable composition using the following Fox equation is at least 373.15 K, preferably at least 393.15 K, more preferably at least 423.15 K:

[0178]

[0179] wherein Tg,i is the glass transition temperature in Kelvin of the homopolymer of component (i) constituting component (A), and w i is the mass fraction of component (i) in component (A),

[0180] Wherein component (A1) comprises or is tricyclodecane di-C 1-20 -alkanol di(meth)acrylates, such as tricyclodecane dimethanol di(meth)acrylate, tricyclodecane diethanol di(meth)acrylate, tricyclodecane dipropanol di(meth)acrylate, tricyclodecane dibutanol di(meth)acrylate, tricyclodecane dipentanol di(meth)acrylate, tricyclodecane di-C6-alkanol di(meth)acrylate, tricyclodecane di-C7-alkanol di(meth)acrylate, tricyclodecane di-C8-alkanol di(meth)acrylate, tricyclodecane di-C9-alkanol di(meth)acrylate, tricyclodecane di-C 10 -Alkyl di(meth)acrylate, tricyclodecane di-C 12 -Alkyl di(meth)acrylate, tricyclodecane di-C 14 -Alkyl di(meth)acrylate, tricyclodecane di-C 16 -Alkyl di(meth)acrylate, tricyclodecane di-C 18 -Alkyl di(meth)acrylate, tricyclodecane di-C 20 -Alkyl alcohol di(meth)acrylate, and any combination thereof.

[0181] In one embodiment, the curable composition of the present invention comprises:

[0182] (A) 97% to 99.5% by weight of at least one component containing an ethylenically unsaturated group, wherein component (A) comprises component (A1) containing a structure (K) selected from an isocyanurate structure and / or a tricyclodecane ring structure; and

[0183] (B) 0.1 to 3% by weight of at least one photoinitiator,

[0184] wherein the amount of component (A1) is in the range of 10 to 90% by weight, preferably 15 to 85% by weight, more preferably 20 to 80% by weight, based on the total amount of component (A),

[0185] wherein the average glass transition temperature (Tg,av) calculated from the curable composition using the following Fox equation is at least 373.15 K, preferably at least 393.15 K, more preferably at least 423.15 K:

[0186]

[0187] wherein Tg,i is the glass transition temperature in Kelvin of the homopolymer of component (i) constituting component (A), and w i is the mass fraction of component (i) in component (A),

[0188] Wherein component (A1) comprises or is tricyclodecane di-C 1-20 -alkanol di(meth)acrylates, such as tricyclodecane dimethanol di(meth)acrylate, tricyclodecane diethanol di(meth)acrylate, tricyclodecane dipropanol di(meth)acrylate, tricyclodecane dibutanol di(meth)acrylate, tricyclodecane dipentanol di(meth)acrylate, tricyclodecane di-C6-alkanol di(meth)acrylate, tricyclodecane di-C7-alkanol di(meth)acrylate, tricyclodecane di-C8-alkanol di(meth)acrylate, tricyclodecane di-C9-alkanol di(meth)acrylate, tricyclodecane di-C 10 -Alkyl di(meth)acrylate, tricyclodecane di-C 12 -Alkyl di(meth)acrylate, tricyclodecane di-C 14 -Alkyl di(meth)acrylate, tricyclodecane di-C 16 -Alkyl di(meth)acrylate, tricyclodecane di-C 18 -Alkyl di(meth)acrylate, tricyclodecane di-C 20 -Alkyl alcohol di(meth)acrylate, and any combination thereof.

[0189] In one embodiment, the curable composition of the present invention comprises:

[0190] (A) 80 to 99.9% by weight of at least one component containing an ethylenically unsaturated group, wherein component (A) comprises component (A1) containing a structure (K) selected from an isocyanurate structure and / or a tricyclodecane ring structure; and

[0191] (B) 0.1 to 8% by weight of at least one photoinitiator,

[0192] wherein the amount of component (A1) is in the range of 10 to 90% by weight, preferably 15 to 85% by weight, more preferably 20 to 80% by weight, based on the total amount of component (A),

[0193] wherein the average glass transition temperature (Tg,av) calculated from the curable composition using the following Fox equation is at least 373.15 K, preferably at least 393.15 K, more preferably at least 423.15 K:

[0194]

[0195] wherein Tg,i is the glass transition temperature in Kelvin of the homopolymer of component (i) constituting component (A), and w i is the mass fraction of component (i) in component (A),

[0196] Wherein component (A1) includes or is tris-(2-hydroxyethyl)isocyanurate tri(meth)acrylate, tris(hydroxymethyl)isocyanurate tri(meth)acrylate, tris(3-hydroxy-n-propyl)isocyanurate tri(meth)acrylate, tricyclodecane dimethanol di(meth)acrylate, tricyclodecane diethanol di(meth)acrylate, tricyclodecane dipropanol di(meth)acrylate, tricyclodecane dibutanol di(meth)acrylate, tricyclodecane dipentanol di(meth)acrylate, tricyclodecane di-C6-alkanol di(meth)acrylate, tricyclodecane di-C7-alkanol di(meth)acrylate, tricyclodecane di-C8-alkanol di(meth)acrylate, tricyclodecane di-C9-alkanol di(meth)acrylate, tricyclodecane di-C 10 -alkanol di(meth)acrylate or any combination thereof.

[0197] In one embodiment, the curable composition of the present invention comprises:

[0198] (A) 90 to 99.9% by weight of at least one component containing an ethylenically unsaturated group, wherein component (A) comprises component (A1) containing a structure (K) selected from an isocyanurate structure and / or a tricyclodecane ring structure; and

[0199] (B) 0.1 to 5% by weight of at least one photoinitiator,

[0200] wherein the amount of component (A1) is in the range of 10 to 90% by weight, preferably 15 to 85% by weight, more preferably 20 to 80% by weight, based on the total amount of component (A),

[0201] wherein the average glass transition temperature (Tg,av) calculated from the curable composition using the following Fox equation is at least 373.15 K, preferably at least 393.15 K, more preferably at least 423.15 K:

[0202]

[0203] wherein Tg,i is the glass transition temperature in Kelvin of the homopolymer of component (i) constituting component (A), and w i is the mass fraction of component (i) in component (A),

[0204] Wherein component (A1) includes or is tris-(2-hydroxyethyl)isocyanurate tri(meth)acrylate, tris(hydroxymethyl)isocyanurate tri(meth)acrylate, tris(3-hydroxy-n-propyl)isocyanurate tri(meth)acrylate, tricyclodecane dimethanol di(meth)acrylate, tricyclodecane diethanol di(meth)acrylate, tricyclodecane dipropanol di(meth)acrylate, tricyclodecane dibutanol di(meth)acrylate, tricyclodecane dipentanol di(meth)acrylate, tricyclodecane di-C6-alkanol di(meth)acrylate, tricyclodecane di-C7-alkanol di(meth)acrylate, tricyclodecane di-C8-alkanol di(meth)acrylate, tricyclodecane di-C9-alkanol di(meth)acrylate, tricyclodecane di-C 10 -alkanol di(meth)acrylate or any combination thereof.

[0205] In one embodiment, the curable composition of the present invention comprises:

[0206] (A) 97% to 99.5% by weight of at least one component containing an ethylenically unsaturated group, wherein component (A) comprises component (A1) containing a structure (K) selected from an isocyanurate structure and / or a tricyclodecane ring structure; and

[0207] (B) 0.1 to 3% by weight of at least one photoinitiator,

[0208] wherein the amount of component (A1) is in the range of 10 to 90% by weight, preferably 15 to 85% by weight, more preferably 20 to 80% by weight, based on the total amount of component (A),

[0209] wherein the average glass transition temperature (Tg,av) calculated from the curable composition using the following Fox equation is at least 373.15 K, preferably at least 393.15 K, more preferably at least 423.15 K:

[0210]

[0211] wherein Tg,i is the glass transition temperature in Kelvin of the homopolymer of component (i) constituting component (A), and w i is the mass fraction of component (i) in component (A),

[0212] Wherein component (A1) includes or is tris-(2-hydroxyethyl)isocyanurate tri(meth)acrylate, tris(hydroxymethyl)isocyanurate tri(meth)acrylate, tris(3-hydroxy-n-propyl)isocyanurate tri(meth)acrylate, tricyclodecane dimethanol di(meth)acrylate, tricyclodecane diethanol di(meth)acrylate, tricyclodecane dipropanol di(meth)acrylate, tricyclodecane dibutanol di(meth)acrylate, tricyclodecane dipentanol di(meth)acrylate, tricyclodecane di-C6-alkanol di(meth)acrylate, tricyclodecane di-C7-alkanol di(meth)acrylate, tricyclodecane di-C8-alkanol di(meth)acrylate, tricyclodecane di-C9-alkanol di(meth)acrylate, tricyclodecane di-C 10 -alkanol di(meth)acrylate or any combination thereof.

[0213] Component (C)

[0214] For practical application, the curable composition of the present invention may optionally further comprise an auxiliary agent as component (C).

[0215] As auxiliary agents, the following preferred examples may be mentioned: surfactants, flame retardants, dyes, pigments, catalysts, UV absorbers and stabilizers (e.g., anti-oxidation, hydrolysis, light, heat or discoloration), inorganic and / or organic fillers, and reinforcing materials. As hydrolysis inhibitors, oligomeric and / or polymeric aliphatic or aromatic carbodiimides are preferred. In order to stabilize the cured material of the invention against aging and destructive environmental influences, in a preferred embodiment, stabilizers are added to the system.

[0216] Surfactant is a surface active compound, such as anionic, cationic, nonionic and amphoteric surfactants and mixtures thereof. Such surfactants can be used as, for example, dispersants, solubilizing agents, etc. Examples of surfactants are listed in McCutcheon's, Vol. 1: Emulsifiers & Detergents [emulsifiers and detergents], McCutcheon's Directories [McCutcheon's catalog], Glen Rock, USA, 2008 (International Edition or North American Edition). Suitable anionic surfactants can be alkali metal salts, alkaline earth metal salts or ammonium salts of sulfonic acid, sulfuric acid, phosphoric acid, carboxylic acids and mixtures thereof. Suitable nonionic surfactants can be alkoxylates, N-substituted fatty acid amides, amine oxides, esters, sugar-based surfactants, polymer surfactants and mixtures thereof. Suitable cationic surfactants can be quaternary surfactants, such as quaternary ammonium compounds with one or two hydrophobic groups, or salts of long-chain primary amines. Suitable amphoteric surfactants can be alkyl betaines and imidazolines.

[0217] More details on the abovementioned additives can be found in the specialist literature, for example in Plastics Additive Handbook, 5th edition, ed. H. Zweifel, Hanzel-Verlag, Munich, 2001.

[0218] When present, the amount of component (C) in the curable composition of the present invention can be in the range of 0% to 18% by weight, such as 1% by weight, 3% by weight, 5% by weight, 7% by weight, 9% by weight, 11% by weight, 13% by weight, 15% by weight, 17% by weight, 18% by weight, preferably 0% to 16% by weight, or 0% to 15% by weight, or 0% to 13% by weight, or 0% to 10% by weight, based on the total weight of the curable composition of the present invention.

[0219] Preparation of composition

[0220] One aspect of the present invention relates to a method of preparing a curable composition of the present invention for 3D printing, the method comprising mixing the components of the composition.

[0221] According to an embodiment of the present invention, the mixing can be carried out under stirring at a temperature in the range of room temperature to about 80°C, such as at a temperature in the range of 30°C to about 80°C, preferably 40°C to about 60°C, for example about 50°C. There is no particular limitation on the mixing time and stirring rate, as long as all components are uniformly mixed together. In a specific embodiment, the mixing can be carried out at 1000 to 3000RPM, preferably 1500 to 2500RPM for 5 to 60min, more preferably 6 to 30min.

[0222] 3D printed objects and their preparation

[0223] One aspect of the present invention relates to a method of forming a 3D printed object, the method comprising using the curable composition of the present invention.

[0224] In one embodiment of the present invention, a method for forming a 3D printed object comprises the following steps:

[0225] (i) applying the curable composition and curing the applied curable composition layer by layer by radiation to form an intermediate 3D printed object; and

[0226] (ii) curing the entire intermediate 3D printed object by radiation to form a cured 3D printed object.

[0227] According to the present invention, the curing time in steps (i) and (ii) can be determined by a technician according to actual applications. For example, in step (i) of the method, the curing time for each layer can be 0.5 to 15 seconds, such as 1 to 10 seconds.

[0228] In step (ii) of the method, the curing time for the entire intermediate 3D printed object can be in the range of 3 min to 500 min, for example 3 min, 5 min, 10 min, 20 min, 30 min, 40 min, 60 min, 80 min, 100 min, 120 min, 180 min, 250 min, 300 min, 400 min, preferably 10 min to 250 min.

[0229] There is no particular limitation on the temperature during step (i) or step (ii). Specifically, the temperature can be selected according to the material and 3D printer used.

[0230] The radiation used in steps (i) and (ii) of the method of forming a 3D printed object of the present invention can be adopted by a technician according to the actual 3D printing application. For example, the radiation can be actinic radiation having sufficient energy to initiate a polymerization or crosslinking reaction. Actinic radiation can include, but is not limited to, α-rays, γ-rays, ultraviolet radiation (UV radiation), visible light, and electron beams, wherein UV radiation and electron beams, especially UV radiation, are preferred.

[0231] In a specific embodiment, the wavelength of the radiated light may be in the range of 350 to 480 nm, for example 355 nm, 365 nm, 385 nm, 395 nm, 405 nm, 420 nm, 440 nm, 460 nm, 480 nm.

[0232] Stereolithography (SLA), digital light processing (DLP), photopolymer jetting (PPJ), LCD technology or other technologies known to those skilled in the art can be used in step (i) of the method of forming a 3D printed object of the present invention. Preferably, the production of a cured 3D object of complex shape is carried out, for example, by stereolithography, which has been known for many years. In this technology, the desired shaped article is constructed from a radiation-curable composition by means of two steps (1) and (2) in a repeated, alternating sequence. In step (1), a layer of radiation-curable composition is cured by means of suitable imaging radiation, preferably imaging radiation from a computer-controlled scanning laser beam, in a surface area corresponding to the desired cross-sectional area of ​​the shaped article to be formed, one boundary of which is the surface of the composition, and in step (2), the cured layer is covered with a new layer of radiation-curable composition, and the sequence of steps (1) and (2) is repeated frequently until the desired shape is achieved.

[0233] The present invention further relates to a 3D printed object formed from the curable composition of the present invention or obtained by the method of the present invention.

[0234] Non-limiting examples of 3D printed objects of the present invention include plastic parts within a vehicle, such as interior parts, connectors, and functional prototypes.

[0235] Examples

[0236] The present invention will be better understood in light of the following non-limiting examples.

[0237] Materials and abbreviations

[0238]

[0239] method

[0240] (1) Heat Deformation Temperature (HDT)

[0241] Heat distortion temperature was determined according to ASTM D648-07.

[0242] (2) Average Tg (Tg,av)

[0243] The average glass transition temperature (Tg,av) in the examples was calculated using the following Fox equation:

[0244]

[0245] wherein Tg,i is the glass transition temperature in Kelvin of the homopolymer of component (i) constituting component (A), and w i is the mass fraction of component (i) in component (A).

[0246] Example 1

[0247] Curable compositions 1-5 were prepared by adding all components listed in Table 1 in the amounts shown in Table 2 to a plastic vial and mixing by a speed mixer at 50° C. at 2000 RPM for 10 minutes to obtain liquid curable compositions.

[0248] The curable compositions 1-5 were printed using a MiiCraft 150 3D printer, which is a desktop digital light processing (DLP) 3D printer with a wavelength of 405 nm. For a typical printing process, the curable composition was loaded into a cylinder in the printer. The detailed printing parameters are summarized as follows: UV energy was 4.75 mW / cm 2 , the base curing time is 6.0s, base layer 1, the curing time is 2.0s, buffer layer 5.

[0249] After the 3D printing process, the obtained object was immersed in ethanol and shaken for 10 seconds to remove the uncured material on the surface, followed by drying using compressed air. After UV post-curing for 40 minutes using a NextDent post-curing unit (LC-3DPrint box), the final object with a smooth dry surface was obtained.

[0250] The HDT of the final objects prepared from each composition is provided in Table 2.

[0251] The mechanical properties of the final objects prepared from each composition are provided in Table 3.

[0252] Table 1. Components of Curable Compositions 1-5

[0253]

[0254] Table 2. Curable compositions 1-5 and corresponding HDT and average Tg (Tg,av)

[0255]

[0256] Table 3 – Mechanical properties

[0257] Composition Young's modulus (MPa) Tensile strength(MPa) Fracture strain (%) 1 3630 61.5 2.80 2 3570 82.8 3.34 3 3486 65.3 2.76 4 3730 85.8 3.16 5 3887 79.4 2.70

[0258] Example 2:

[0259] Curable compositions 6-7 and Comparative composition 1 were prepared by adding all components listed in Table 4 in the amounts shown in Table 5 to a plastic vial and mixing by a speed mixer at 50° C. at 2000 RPM for 10 minutes to obtain liquid curable compositions.

[0260] The curable compositions 6-7 and the comparative composition 1 were printed using a MiiCraft 150 3D printer, which is a desktop digital light processing (DLP) 3D printer with a wavelength of 405 nm. For a typical printing process, the curable composition was loaded into a cylinder in the printer. The detailed printing parameters are summarized as follows: UV energy was 4.75 mW / cm 2 , the base curing time is 6.0s, base layer 1, the curing time is 2.0s, buffer layer 5.

[0261] After the 3D printing process, the obtained object was immersed in ethanol and shaken for 10 seconds to remove the uncured material on the surface, followed by drying using compressed air. After UV post-curing for 40 minutes using a NextDent post-curing unit (LC-3DPrint box), the final object with a smooth dry surface was obtained.

[0262] The HDT of the final objects prepared from each composition is provided in Table 5.

[0263] The mechanical properties of the final objects prepared from each composition are provided in Table 6.

[0264] Table 4. Components of Curable Compositions 6-7 and Comparative Composition 1

[0265]

[0266] Table 5. Curable compositions 6-7, comparative composition 1, and corresponding HDT and average Tg (Tg,av)

[0267]

[0268] Table 6 – Mechanical properties

[0269]

[0270] Example 3:

[0271] Curable compositions 8-11 were prepared by adding all components listed in Table 7 in the amounts shown in Table 8 to a plastic vial and mixing by a speed mixer at 50° C. at 2000 RPM for 10 minutes to obtain liquid curable compositions.

[0272] The curable compositions 8-11 were printed using a MiiCraft 150 3D printer, which is a desktop digital light processing (DLP) 3D printer with a wavelength of 405 nm. For a typical printing process, the curable composition was loaded into a cylinder in the printer. The detailed printing parameters are summarized as follows: UV energy was 4.75 mW / cm 2 , the base curing time is 6.0s, base layer 1, the curing time is 2.0s, buffer layer 5.

[0273] After the 3D printing process, the obtained object was immersed in ethanol and shaken for 10 seconds to remove the uncured material on the surface, followed by drying using compressed air. After UV post-curing for 40 minutes using a NextDent post-curing unit (LC-3DPrint box), the final object with a smooth dry surface was obtained.

[0274] The HDT of the final objects prepared from each composition is provided in Table 8.

[0275] Table 7. Components of Curable Compositions 8-11

[0276]

[0277] Table 8. Curable compositions 8-11 and corresponding HDT and average Tg (Tg,av)

[0278]

[0279] Example 4:

[0280] Curable composition 12 was prepared by adding all components listed in Table 9 in the amounts shown in Table 10 to a plastic vial and mixing by a speed mixer at 50° C. at 2000 RPM for 10 minutes to obtain a liquid curable composition.

[0281] The curable composition 12 was printed using a MiiCraft 150 3D printer, which is a desktop digital light processing (DLP) 3D printer with a wavelength of 405 nm. For a typical printing process, the curable composition 12 was loaded into a cylinder in the printer. The detailed printing parameters are summarized as follows: UV energy was 4.75 mW / cm 2 , the base curing time is 6.0s, base layer 1, the curing time is 2.0s, buffer layer 5.

[0282] After the 3D printing process, the obtained object was immersed in ethanol and shaken for 10 seconds to remove the uncured resin on the surface, followed by drying using compressed air. After UV post-curing for 40 minutes using a NextDent post-curing unit (LC-3DPrint box), the final object with a smooth dry surface was obtained.

[0283] The HDT of the final objects made from Composition 12 are provided in Table 10.

[0284] The mechanical properties of the final objects made from composition 12 are provided in Table 11.

[0285] Table 9. Components of Curable Composition 12

[0286]

[0287]

[0288] Table 10. Curable compositions 12 and corresponding HDT and average Tg (Tg,av)

[0289]

[0290] Table 11 – Mechanical properties

[0291]

Claims

1. A curable composition comprising: (A) at least one component containing an ethylenically unsaturated group, wherein component (A) comprises component (A1) containing a structure (K) selected from an isocyanurate structure and / or a tricyclodecane ring structure; and (B) at least one photoinitiator, wherein the average glass transition temperature (Tg,av) calculated from the curable composition using the following Fox equation is at least 373.15 K, preferably at least 393.15 K, more preferably at least 423.15 K: wherein Tg,i is the glass transition temperature in Kelvin of the homopolymer of component (i) constituting component (A), and w i is the mass fraction of component (i) in component (A).

2. The curable composition according to claim 1, wherein Component (A1) contains at least 1 ethylenically unsaturated group, preferably 1 to 5 ethylenically unsaturated groups, more preferably 2 to 4 ethylenically unsaturated groups.

3. The curable composition according to claim 1 or 2, wherein The ethylenically unsaturated group is selected from the group consisting of allyl, vinyl, acrylate, methacrylate, acryloxy, methacryloyloxy, acrylamide, methacrylamide, ethynyl, and maleimide.

4. The curable composition according to any one of claims 1 to 3, wherein Component (A1) includes or is tri(hydroxy-C 1-30 -alkyl) isocyanurate tri(meth)acrylate, preferably, component (A1) includes or comprises tri(2-hydroxyethyl)isocyanurate tri(meth)acrylate, tri(hydroxymethyl)isocyanurate tri(meth)acrylate, tri(3-hydroxy-n-propyl)isocyanurate tri(meth)acrylate, or any combination thereof.

5. The curable composition according to any one of claims 1 to 4, wherein Component (A1) includes or is tricyclodecane-di-C 1-20 -Alkanol di(meth)acrylate, preferably tricyclodecane dimethanol di(meth)acrylate, tricyclodecane diethanol di(meth)acrylate, tricyclodecane dipropanol di(meth)acrylate, tricyclodecane dibutanol di(meth)acrylate, or tricyclodecane dipentanol di(meth)acrylate.

6. The curable composition according to any one of claims 1 to 5, wherein The photoinitiator is a free radical photoinitiator and / or an ionic photoinitiator, preferably a free radical photoinitiator.

7. The curable composition according to any one of claims 1 to 6, wherein The amount of component (A) ranges from 80 to 99.9% by weight, preferably from 90 to 99.9% by weight, more preferably from 97 to 99.5% by weight, based on the total amount of the curable composition.

8. The curable composition according to any one of claims 1 to 7, wherein The amount of component (A1) ranges from 10 to 90% by weight, preferably from 15 to 85% by weight, more preferably from 20 to 80% by weight, based on the total amount of component (A).

9. The curable composition according to any one of claims 1 to 8, wherein The amount of the photoinitiator ranges from 0.1 to 8% by weight, preferably from 0.1 to 5% by weight, more preferably from 0.5 to 3% by weight, based on the total amount of the curable composition.

10. The curable composition according to any one of claims 1 to 9, further comprising an auxiliary as component (C) such as a surfactant, a flame retardant, a pigment, a filler, a dye, a catalyst, a UV absorber and a stabilizer, and a reinforcing material, preferably in an amount ranging from 0 to 18% by weight, preferably from 0 to 15% by weight, more preferably from 0 to 10% by weight, based on the total amount of the curable composition.

11. The curable composition according to any one of claims 1 to 10, wherein The cured product formed from the curable composition has a HDT value of at least 100°C, preferably at least 140°C, more preferably at least 190°C under a load of 1.82 MPa as measured according to test standard ASTM D648-07.

12. The curable composition according to any one of claims 1 to 11, wherein Component (A) further comprises component (A2) which does not contain structure (K).

13. A method of forming a 3D printed object, the method comprising using the curable composition according to any one of claims 1 to 12.

14. The method according to claim 13, comprising: (i) applying the curable composition and curing the applied curable composition layer by layer by radiation to form an intermediate 3D printed object; and (ii) curing the entire intermediate 3D printed object by radiation to form a cured 3D printed object.

15. The method according to claim 14, wherein: The intermediate 3D printed object is formed in step (i) using stereolithography, photopolymer jetting, digital light processing or LCD technology.

16. The method according to claim 14 or 15, wherein: The radiation is UV radiation.

17. A 3D printed object formed from the curable composition according to any one of claims 1 to 12 or obtained by the method according to any one of claims 13 to 16.

18. The 3D printed object according to claim 17, wherein: The 3D printed objects include plastic parts within the vehicle, such as interior components, connectors, and functional prototypes.

Citation Information

Patent Citations

  • Hydrolysis resistant soluble bis:acyl-bis:phosphine oxide and sulphide

    DE19618720A1

  • radiation-curable compositions containing phenylglyoxylates

    DE19826712A1

  • Use of phenylglyoxalic acid esters as photoinitiators

    DE19913353A1

  • Bisacylphosphines

    EP0495751A1

  • Non-volatile phenylglyoxalic esters

    WO1998033761A1